David Velasco

782 total citations
10 papers, 494 citations indexed

About

David Velasco is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, David Velasco has authored 10 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 4 papers in Epidemiology and 4 papers in Clinical Biochemistry. Recurrent topics in David Velasco's work include Bacterial Identification and Susceptibility Testing (4 papers), Antibiotic Resistance in Bacteria (3 papers) and Vibrio bacteria research studies (2 papers). David Velasco is often cited by papers focused on Bacterial Identification and Susceptibility Testing (4 papers), Antibiotic Resistance in Bacteria (3 papers) and Vibrio bacteria research studies (2 papers). David Velasco collaborates with scholars based in Spain and Peru. David Velasco's co-authors include Rosa Villanueva, Germán Bou, Rita Moure, María Tomás, Alejandro Beceiro, Astrid Pérez, Mónica Cartelle Gestal, Francisca Molina, J Martínez-Beltrán and Remedios Guna and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

David Velasco

10 papers receiving 465 citations

Peers

David Velasco
Jae Il Yoo South Korea
Jung Sik Yoo South Korea
Rebecca A. Hutton United States
M.-N. Kim South Korea
Hayley J. Brodrick United Kingdom
Pia Littauer Denmark
Jae Il Yoo South Korea
David Velasco
Citations per year, relative to David Velasco David Velasco (= 1×) peers Jae Il Yoo

Countries citing papers authored by David Velasco

Since Specialization
Citations

This map shows the geographic impact of David Velasco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Velasco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Velasco more than expected).

Fields of papers citing papers by David Velasco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Velasco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Velasco. The network helps show where David Velasco may publish in the future.

Co-authorship network of co-authors of David Velasco

This figure shows the co-authorship network connecting the top 25 collaborators of David Velasco. A scholar is included among the top collaborators of David Velasco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Velasco. David Velasco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Rodríguez‐Segade, S., David Velasco, & Pedro J. Marcos. (2015). Empyema due to Aggregatibacter aphrophilus and Parvimonas micra Coinfection. Archivos de Bronconeumología. 51(5). 254–255. 6 indexed citations
2.
Dahbi, Ghizlane, Azucena Mora, Cecilia López, et al.. (2013). Emergence of new variants of ST131 clonal group among extraintestinal pathogenic Escherichia coli producing extended-spectrum β-lactamases. International Journal of Antimicrobial Agents. 42(4). 347–351. 47 indexed citations
3.
Cantón, Rafael, Javier Pemán, Guillermo Quindós, et al.. (2011). Prospective Multicenter Study of the Epidemiology, Molecular Identification, and Antifungal Susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis Isolated from Patients with Candidemia. Antimicrobial Agents and Chemotherapy. 55(12). 5590–5596. 122 indexed citations
4.
Velasco, David, María Tomás, Mónica Cartelle Gestal, et al.. (2005). Evaluation of different methods for detecting methicillin (oxacillin) resistance in Staphylococcus aureus. Journal of Antimicrobial Chemotherapy. 55(3). 379–382. 142 indexed citations
5.
Guerrero, Antonio, et al.. (2005). Prevalencia de resistencia a los fármacos antirretrovirales en pacientes españoles infectados por el VIH y sin tratamiento previo. Enfermedades Infecciosas y Microbiología Clínica. 23(10). 605–608. 4 indexed citations
6.
Tomás, María, Alejandro Beceiro, Astrid Pérez, et al.. (2005). Cloning and Functional Analysis of the Gene Encoding the 33- to 36-Kilodalton Outer Membrane Protein Associated with Carbapenem Resistance in Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy. 49(12). 5172–5175. 90 indexed citations
7.
Velasco, David, Sonia Pérez‐Castro, F. J. García Peña, et al.. (2004). Lack of correlation between phenotypic techniques and PCR-based genotypic methods for identification of Enterococcus spp.. Diagnostic Microbiology and Infectious Disease. 49(3). 151–156. 25 indexed citations
8.
Gestal, Mónica Cartelle, María Tomás, Sónia Pértega-Díaz, et al.. (2004). Risk Factors for Colonization and Infection in a Hospital Outbreak Caused by a Strain of Klebsiella pneumoniae with Reduced Susceptibility to Expanded-Spectrum Cephalosporins. Journal of Clinical Microbiology. 42(9). 4242–4249. 40 indexed citations
9.
Durán-Valle, María Teresa, et al.. (2003). Susceptibilidad antifúngica de aislados de Candida spp. de hemocultivos en un período de cinco años (1997-2001). Enfermedades Infecciosas y Microbiología Clínica. 21(9). 488–492. 13 indexed citations
10.
Velasco, David, et al.. (2002). Eficacia de dos métodos semiautomáticos para la exclusión de bacteriuria. Enfermedades Infecciosas y Microbiología Clínica. 20(1). 22–24. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026